Kristen Harrington-Smith's Net Worth

$740 Thousand

Estimate Recalculated Jun 13, 2024 05:47PM EST

Who is Kristen Harrington-Smith?

Kristen Harrington-Smith does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include ImmunoGen, Inc., and eFFECTOR Therapeutics, Inc..

SEC CIK

Kristen Harrington-Smith's CIK is 0001894310

Past Insider Trading and Trends

2022 was Kristen Harrington-Smith's most active year for acquiring shares with 3 total transactions. Kristen Harrington-Smith's most active month to acquire stocks was the month of October. 2022 was Kristen Harrington-Smith's most active year for disposing of shares, totalling 1 transactions. Kristen Harrington-Smith's most active month to dispose stocks was the month of October. 2021 saw Kristen Harrington-Smith paying a total of $2,556,000.00 for 525,000 shares, this is the most they've acquired in one year. In 2022 Kristen Harrington-Smith cashed out on 25,000 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ImmunoGen, Inc. (IMGN) Snapshot price: $29.595

SVP & CHIEF COMMERCIAL OFFICER

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
25K
—
—
25K
Nov 15
Form 4
—
0
—
—
0
Nov 15
Form 3
—
0
—
—
0
No matching records found

eFFECTOR Therapeutics, Inc. (EFTR) Snapshot price: $10.19

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Feb 19
Form 4
—
0
—
—
0
Jun 22
Form 4
—
0
—
—
0
Jan 20
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Feb 15
Form 3
—
0
—
—
0
No matching records found